Targeted Oral Delivery of Paclitaxel Using Colostrum-Derived Exosomes

SIMPLE SUMMARY: Paclitaxel (PAC) is a widely used antitumor agent in the treatment of various early-stage and advanced cancers, including lung cancer. While efficacious, solvent-based PAC generally is not well tolerated and is associated with severe side effects. To overcome such limitations, natura...

Descripción completa

Detalles Bibliográficos
Autores principales: Kandimalla, Raghuram, Aqil, Farrukh, Alhakeem, Sara S., Jeyabalan, Jeyaprakash, Tyagi, Neha, Agrawal, Ashish, Yan, Jun, Spencer, Wendy, Bondada, Subbarao, Gupta, Ramesh C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345039/
https://www.ncbi.nlm.nih.gov/pubmed/34359601
http://dx.doi.org/10.3390/cancers13153700

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345039/
https://www.ncbi.nlm.nih.gov/pubmed/34359601
http://dx.doi.org/10.3390/cancers13153700

Ejemplares similares